RxDoctor Payments Data

Sherilyn Donnelly, NP

Family · Mobile, ALNPI 1689911414

Payments from drug & device makers

$1,449in general payments, 2019–2025

Across 86 payments — averaging $16.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$279
  • Lilly USA, LLC$149
  • Bayer$125
  • Johnson & Johnson$89
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$80
  • Amarin Pharma, Inc.$78
  • plus $649 from 18 others

What the payments were for

  • Food & beverage$1,449100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,449 in reported general payments places this provider in the 70th percentile of 3,415 family providers in Alabama.

See all family providers in Alabama

Medicare billing

Part B allowed, 2024
$35,956
Medicare patients
188
Services billed
943

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide21$36,503
OzempicSemaglutide22$30,396
JardianceEmpagliflozin17$22,738
EliquisApixaban19$21,403
Xigduo XrDapaglifloz Propaned/Metformin18$16,618
VascepaIcosapent Ethyl17$14,020
MyrbetriqMirabegron11$13,718
TrulicityDulaglutide13$12,117
ShingrixVaricella-Zoster Ge/As01b/Pf14$2,539
Atorvastatin Calcium162$1,826
Rosuvastatin Calcium84$1,426
Omeprazole77$1,325
Levothyroxine Sodium81$1,137
Losartan Potassium54$868
Lisinopril100$709

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$149$48,62034 claims
Novo NordiskOzempic$70$30,39622 claims
PfizerEliquis$68$21,40319 claims
GSKShingrix$55$2,53914 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,415 family providers in Alabama.

Other family in Mobile

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →